Signaling Satiety Centers in the Brain In addition to making you feel satisfied after eating by slowing digestion, GLP-1 receptor agonists can also send signals to your brain that reduce cravings
Function: Transports long-chain fatty acids into mitochondria for energy production
Brain Health and Neurological Benefits Exciting research shows that GLP-1 medications may have impressive effects on brain health: They reduce the risk of Alzheimers disease and dementia They help protect against Parkinsons disease They lower the risk of seizures They may reduce stroke risk and improve recovery after stroke They show benefits for Huntingtons disease in early studies A January 2025 study from Washington University found that people taking GLP-1 medications had a decreased risk of neurocognitive disorders like Alzheimers
The Phase 2 VISTA trial demonstrated that Elecoglipron (AZD5004), a once-daily oral small-molecule GLP-1 receptor agonist, achieved up to 11.8% mean weight loss at 36 weeks in adults with obesity or overweight without diabetes
Due to oxidative stress caused by iron and ferroptosis caused by excitatory amino acid synergy, a large number of clinical trials on anti-amino acid toxicity and antioxidative stress treatment have been conducted
Richardson is dedicated to providing personalized and effective care for her patients